Rephonic
Artwork for Oncology Today

Oncology Today with Dr Neil Love

Dr. Neil Love
Immunotherapy
Clinical Trials
Antibody-Drug Conjugates
PARP Inhibitors
Breast Cancer
Colorectal Cancer
Ovarian Cancer
Multiple Myeloma
Prostate Cancer
Endometrial Cancer
Chronic Lymphocytic Leukemia
Non-Hodgkin Lymphoma
Chemotherapy
CAR T-Cell Therapy
Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Pembrolizumab
Metastatic Breast Cancer
Acute Myeloid Leukemia
Circulating Tumor DNA

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

PublishesDailyEpisodes461Founded6 years ago
Number of ListenersCategories
Health & FitnessMedicineScience

Listen to this Podcast

Artwork for Oncology Today

Latest Episodes

Featuring perspectives from Dr Sara A Hurvitz, Dr Erica Mayer, Dr Joyce O’Shaughnessy, Dr Sara M Tolaney and Dr Nicholas Turner, moderated by Dr Tolaney, including the following topics:

• Introduction (0:00)

• Current and Future Roles of Agents Targ... more

Featuring perspectives from Dr Bradley J Monk, Dr David M O’Malley, Ms Kathryn M Schlenker and Ms Jaclyn Shaver, moderated by Dr O’Malley, including the following topics:

• Introduction (00:00)

• Overview of Ovarian Cancer (OC) (2:12)

• Role of PAR... more

YouTube

Featuring perspectives from Dr Melissa Alsina, Dr Hans Lee, Dr Sagar Lonial and Dr Paul G Richardson, moderated by Dr Lonial, including the following topics:

• Introduction (0:00)

• Integrating Bispecific Antibodies into the Management of Relapsed/R... more

YouTube

Featuring perspectives from Dr Sarah B Goldberg, Dr Jonathan Goldman, Dr Joel W Neal, Dr Antonio Passaro and Dr Jacob Sands, moderated by Dr Sands, including the following topics:

• Introduction (00:00)

• Evolving First-Line Treatment for Metastatic... more

YouTube

Featuring perspectives from Dr Floor J Backes, Dr Brian M Slomovitz and Dr Shannon N Westin, moderated by Dr Westin, including the following topics:

• Introduction (00:00)

• Current Up-Front Chemoimmunotherapeutic Approaches for Advanced Endometrial... more

YouTube

Featuring an interview with Prof Dr Sibylle Loibl, including the following topics:

• Perspectives on overall survival gains achieved over the years for patients with metastatic breast cancer (mBC) (0:00)

• Previous treatment and patient outcomes in ... more

YouTube

Featuring perspectives from Dr Farrukh T Awan, Dr Brad S Kahl, Ms Robin Klebig and Ms Mollie Moran, moderated by Dr Kahl, including the following topics:

• Introduction: Biology of Non-Hodgkin Lymphoma (NHL) (00:00)

• Current Role of CD20 x CD3 Bisp... more

YouTube

Featuring perspectives from Dr Ramez N Eskander, Dr Ursula Matulonis, Dr Kathleen N Moore, Dr Alexander B Olawaiye and Dr David M O'Malley, moderated by Dr Moore, including the following topics:

• Introduction (00:00)

• Current Role of PARP Inhibito... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Melissa Alsina
Teleported-in faculty member from the Moffitt Cancer Center
Moffitt Cancer Center
Episode: Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Fred Divers
General medical oncologist presenting cases
Multiple institutions; Yale context implied
Episode: EGFR-Mutated Non-Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Susmita Apuri
General medical oncologist presenting cases
Friendship with faculty; multiple institutions mentioned
Episode: EGFR-Mutated Non-Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Priya Rudolf
General medical oncologist presenting cases
Academic medical centers mentioned
Episode: EGFR-Mutated Non-Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Floor Backes
Faculty presenter discussing upfront chemo-immunotherapy and biomarkers
The Ohio State University
Episode: Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Brian Slomovitz
Faculty presenter discussing ongoing and investigational therapies
Mount Sinai Medical Center
Episode: Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Hal Burstein
From Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: Localized HR-Positive Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Dr. Letterman
Investigator involved in neoadjuvant IO studies in endometrial cancer
Episode: Endometrial Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women’s Cancer
Dr. Secord
Endometrial cancer specialist
Episode: Endometrial Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women’s Cancer

Host

Neil Love
Multiple episode host with affiliations to Research To Practice and Oncology Today-related programs; central figure guiding many interviews.

Top Science Podcasts

Something You Should Know
Something You Should KnowMike Carruthers | OmniCast Media
Radiolab
RadiolabWNYC Studios
Hidden Brain
Hidden BrainHidden Brain, Shankar Vedantam
StarTalk Radio
StarTalk RadioNeil deGrasse Tyson
Health Optimization Medicine Podcast
Health Optimization Medicine PodcastHealth Optimization Medicine and Practice
Are We Doomed?
Are We Doomed?NPR Network
Big Ideas Lab
Big Ideas LabMission.org
Sasquatch Chronicles
Sasquatch ChroniclesSasquatch Chronicles - Bigfoot Encounters
Science Friday
Science FridayScience Friday and WNYC Studios

Talking Points

Recent interactions between the hosts and their guests.

Antibody-Drug Conjugates in the Management of Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Q: What is the role of PD-L1 status in selecting ADCs vs. immunotherapy combinations?
PD-L1 status informs whether immunotherapy is likely to add benefit, particularly in combinations like SG with pembrolizumab; however, some ADCs (e.g., certain TROPO2 agents) show activity regardless of PD-L1, and ongoing trials are clarifying when to prioritize ADCs alone vs. in combination with IO.
Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay
Q: Why might intermittent therapy be considered, and how does EMBARQ inform its real-world application?
Intermittent therapy relies on cycles of treatment and off periods guided by PSA and response; EMBARQ demonstrated a meaningful off period only in extreme responders with centralized PSA monitoring, suggesting careful patient selection and real-world variability in practice.
Androgen Deprivation Therapy for Prostate Cancer — An Interview with Dr Rana R McKay
Q: What is the MOA difference between androgen receptor agonists and antagonists in ADT, and how does that translate into endocrine profiles?
Antagonists block the GnRH receptor, causing a rapid and deeper drop in LH/FSH and testosterone, whereas agonists initially stimulate the axis and then cause a rebound followed by suppression; this yields different endocrine dynamics and potentially different cardiovascular implications.
Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft
Q: What happened to the patient who received induction therapy with carboplatin, paclitaxel, and nivolumab?
The patient had a strong tumor and nodal response but developed hypothyroidism; after three cycles, the treatment was halted due to toxicity concerns and planning around surgery.
Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft
Q: What were the options in this case, and how did you decide on induction therapy?
Options ranged from upfront surgery with adjuvant therapy to induction chemoimmunotherapy followed by surgery, or chemoradiation with subsequent adjuvant immunotherapy; decision depended on operability, resectability, and patient lung function.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Oncology Today

What is Oncology Today about and what kind of topics does it cover?

Medical oncology-focused conversations feature in-depth interviews and panel discussions with leading cancer researchers and clinicians. Episodes emphasize practical decision-making in biomarker-driven therapy, targeted agents, immunotherapy, and emerging diagnostic technologies, often anchored by real patient cases and community oncologist perspectives. Across samples, themes include PARP inhibitors in prostate cancer, ctDNA/MRD-guided colorectal cancer strategies, and the integration of novel agents (e.g., CELMoDs, antibody-drug conjugates) into front-line and relapse settings. Notable is the strong emphasis on translating trial data into everyday practice, including testing strategies, sequencing decisions, toxicity management, and the e... more

Where can I find podcast stats for Oncology Today?

Rephonic provides a wide range of podcast stats for Oncology Today. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Oncology Today and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Oncology Today get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Oncology Today, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Oncology Today?

Rephonic provides comprehensive predictive audience data for Oncology Today, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Oncology Today have?

To see how many followers or subscribers Oncology Today has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Oncology Today?

These podcasts share a similar audience with Oncology Today:

1. Two Onc Docs
2. Research To Practice | Oncology Videos
3. Oncology Brothers: Practice-Changing Cancer Discussions
4. Breast Cancer Update
5. OncLive® On Air

How many episodes of Oncology Today are there?

Oncology Today launched 6 years ago and published 461 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Oncology Today?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Oncology Today?

Rephonic pulls ratings and reviews for Oncology Today from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Oncology Today?

Rephonic provides full transcripts for episodes of Oncology Today. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Oncology Today?

Recent guests on Oncology Today include:

1. Melissa Alsina
2. Fred Divers
3. Susmita Apuri
4. Priya Rudolf
5. Floor Backes
6. Brian Slomovitz
7. Hal Burstein
8. Dr. Letterman

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days